Regions Financial Corp Pfizer Inc Transaction History

Regions Financial Corp

$13.8 Billion
Q3 2024

A detailed history of Regions Financial Corp transactions in Pfizer Inc stock. As of the latest transaction made, Regions Financial Corp holds 328,405 shares of PFE stock, worth $8.68 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

328,405

Previous 350,595 6.33%

Holding current value

$8.68 Million

Previous $9.81 Million 3.11%

% of portfolio

0.07%

Previous 0.07%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $614,663 - $696,544	-22,190 Reduced 6.33%	328,405 $9.5 Million
Q2 2024 Jul 31, 2024	SELL	$25.26 - $29.6 $1.43 Million - $1.67 Million	-56,507 Reduced 13.88%	350,595 $9.81 Million
Q1 2024 Apr 23, 2024	SELL	$25.89 - $29.73 $473,010 - $543,167	-18,270 Reduced 4.3%	407,102 $11.3 Million
Q4 2023 Feb 06, 2024	SELL	$26.13 - $33.94 $301,696 - $391,871	-11,546 Reduced 2.64%	425,372 $12.2 Million
Q3 2023 Nov 01, 2023	SELL	$32.09 - $37.51 $216,414 - $252,967	-6,744 Reduced 1.52%	436,918 $14.5 Million
Q2 2023 Aug 09, 2023	SELL	$36.12 - $41.79 $38,937 - $45,049	-1,078 Reduced 0.24%	443,662 $16.3 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $562,449 - $732,227	-14,279 Reduced 3.11%	444,740 $18.1 Million
Q4 2022 Feb 03, 2023	SELL	$41.75 - $54.5 $691,797 - $903,065	-16,570 Reduced 3.48%	459,019 $23.5 Million
Q3 2022 Nov 03, 2022	SELL	$43.76 - $53.42 $412,481 - $503,536	-9,426 Reduced 1.94%	475,589 $20.8 Million
Q2 2022 Jul 25, 2022	SELL	$46.53 - $55.17 $12,981 - $15,392	-279 Reduced 0.06%	485,015 $25.4 Million
Q1 2022 Apr 25, 2022	SELL	$45.75 - $56.69 $261,552 - $324,096	-5,717 Reduced 1.16%	485,294 $25.1 Million
Q4 2021 Jan 31, 2022	SELL	$41.32 - $61.25 $618,395 - $916,667	-14,966 Reduced 2.96%	491,011 $29 Million
Q3 2021 Nov 04, 2021	SELL	$39.25 - $50.42 $1.02 Million - $1.31 Million	-25,888 Reduced 4.87%	505,977 $21.8 Million
Q2 2021 Jul 27, 2021	SELL	$35.91 - $40.68 $166,047 - $188,104	-4,624 Reduced 0.86%	531,865 $20.8 Million
Q1 2021 Jun 02, 2021	SELL	$33.49 - $37.77 $602,853 - $679,897	-18,001 Reduced 3.25%	536,489 $19.4 Million
Q4 2020 Feb 05, 2021	SELL	$33.47 - $42.56 $1.32 Million - $1.67 Million	-39,304 Reduced 6.62%	554,490 $20.4 Million
Q3 2020 Oct 15, 2020	SELL	$31.75 - $37.25 $1.2 Million - $1.41 Million	-37,916 Reduced 6.0%	593,794 $21.8 Million
Q2 2020 Jul 27, 2020	SELL	$30.12 - $36.54 $966,129 - $1.17 Million	-32,076 Reduced 4.83%	631,710 $20.7 Million
Q1 2020 Apr 29, 2020	SELL	$27.03 - $38.62 $1.66 Million - $2.37 Million	-61,331 Reduced 8.46%	663,786 $21.7 Million
Q4 2019 Feb 03, 2020	SELL	$32.92 - $37.36 $3.8 Million - $4.31 Million	-115,358 Reduced 13.73%	725,117 $28.4 Million
Q3 2019 Oct 24, 2019	SELL	$32.49 - $42.13 $17.2 Million - $22.3 Million	-529,849 Reduced 38.67%	840,475 $30.2 Million
Q2 2019 Jul 19, 2019	SELL	$36.98 - $41.52 $7.56 Million - $8.49 Million	-204,440 Reduced 12.98%	1,370,324 $59.4 Million
Q1 2019 Apr 19, 2019	SELL	$37.5 - $41.2 $36.8 Million - $40.5 Million	-981,870 Reduced 38.4%	1,574,764 $66.9 Million
Q4 2018 Jan 28, 2019	SELL	$38.47 - $43.86 $16.9 Million - $19.3 Million	-439,389 Reduced 14.67%	2,556,634 $112 Million
Q3 2018 Oct 22, 2018	SELL	$34.47 - $41.81 $2.15 Million - $2.6 Million	-62,295 Reduced 2.04%	2,996,023 $132 Million
Q2 2018 Jul 26, 2018	SELL	$32.98 - $35.16 $2.48 Million - $2.65 Million	-75,282 Reduced 2.4%	3,058,318 $111 Million
Q1 2018 Apr 18, 2018	SELL	$31.91 - $37.02 $16,146 - $18,732	-506 Reduced 0.02%	3,133,600 $111 Million
Q4 2017 Jan 18, 2018	SELL	$33.26 - $35.29 $3.08 Million - $3.27 Million	-92,566 Reduced 2.87%	3,134,106 $114 Million
Q3 2017 Oct 23, 2017	BUY	$31.0 - $34.15 $100 Million - $110 Million	3,226,672	3,226,672 $115 Million

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Regions Financial Corp with notifications on news.

Account

Regions Financial Corp Pfizer Inc Transaction History